Format

Send to

Choose Destination
Curr Top Med Chem. 2015;15(17):1663-72.

Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.

Author information

1
Departamento de Quimica Organica y Fisicoquimica, Facultad de Ciencias QuĂ­micas Y Farmaceuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile. raraya@ciq.uchile.cl.

Abstract

Curcumin, a natural yellow polyphenol, is isolated from the herb Curcuma longa L. (turmeric), a member of the ginger family. It has been extensively studied due to their multiple pharmacological properties. Nevertheless, curcumin has disadvantages such as poor water solubility, poor bioavailability and rapid metabolism, which has prompted the search for analogues that overcome these shortcomings while maintaining or improving their good pharmacological properties. Among the main curcumin analogues that have been developed, the heterocyclic curcuminoids show a high interest. In this review, we describe recent progress in the synthesis and pharmacological properties of new heterocyclic curcumin derivatives. The most recent developments in anti-cancer, anti-Alzheimer, anti-bacterial and anti-oxidants heterocyclic curcumin derivatives are covered.

PMID:
25915614
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center